Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single‐center retrospective analysis
- 10 August 2018
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 45 (10) , 1191-1194
Abstract
Although the role of sentinel lymph node biopsy (SLNB) as a prognostic factor is well established, its consequences for therapy are controversial. The aim of this study was to analyze if complete lymph node dissection (CLND) in patients with more than one positive sentinel lymph node (SLN) significantly improves melanoma‐specific survival (MSS) and progression‐free survival (PFS). Medical records of patients who underwent SLNB between 2001 and 2016 at the University Hospital of Cologne were reviewed, and patients with positive SLN were identified. Patient and tumor characteristics, patterns of recurrence, progression‐free and melanoma‐specific survival were analyzed. Seventy‐eight patients with multiple positive and 197 patients with one positive SLN were included in this study. Patients with multiple positive SLN had significantly more positive non‐SLN compared with patients with only one positive SLN (26.9% vs 8.6%, P = 0.01). However, in the subgroup of patients with multiple positive SLN, CLND did not significantly improve MSS (mean MSS 95 vs 75 months, P = 0.5) and PFS (mean PFS 59 vs 68 months P = 0.167). CLND did not result in a significant improvement in PFS and MSS in patients with multiple positive SLN.Keywords
This publication has 13 references indexed in Scilit:
- Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaNew England Journal of Medicine, 2017
- S3‐Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms – Update 2015/2016, Kurzversion 2.0JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2017
- The impact of sentinel node dissection on disease‐free and overall tumour‐specific survival in melanoma patients: a single centre group‐matched analysis of 1192 patientsJournal of the European Academy of Dermatology and Venereology, 2016
- Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in MelanomaJournal of the American College of Surgeons, 2016
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trialThe Lancet Oncology, 2016
- Association of Sentinel Lymph Node Biopsy With Survival for Head and Neck MelanomaJAMA Otolaryngology–Head & Neck Surgery, 2014
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in MelanomaNew England Journal of Medicine, 2014
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- The Amount of Metastatic Melanoma in a Sentinel Lymph Node: Does It Have Prognostic Significance?Annals of Surgical Oncology, 2003
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992